

University of California San Francisco
Give to UCSFLearn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
The National Institutes of Health (NIH) has awarded 10 grants this year to UC San Francisco researchers as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.
The awards to UCSF total more than $40 million and will fund projects ranging from better technologies for MRI imaging of back pain, to the use of deep-brain stimulation for treating chronic pain, to a new interdisciplinary research center for low back pain.
In 2016, an estimated 50 million U.S. adults suffered from chronic pain – generally defined as pain that lasts more than three months – and low back pain, headaches, arthritis, neuropathy and other forms cost about $635 billion annually. In 2018, an estimated 10.3 million Americans age 12 and older misused opioids, including heroin.
Several of the grants to UCSF focus on low back pain, a common yet hard-to-treat condition. According to the Global Burden of Disease 2010 Study, low back pain ranked highest in terms of years lived with disability, yet no consistently effective and durable pharmacologic intervention exists for chronic low back pain, though opioids are a common treatment.
The largest of the new grants, $29.4 million, will go to creating the Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain (REACH) at UCSF, an interdisciplinary consortium of basic and clinical scientists working to define different types of chronic low back pain and pain mechanisms that may lead to effective, personalized treatments for patients. REACH will be led by Jeffrey C. Lotz, PhD, professor and vice chair of research in Orthopaedic Surgery.
Other UCSF projects that received HEAL funding:
The NIH launched the HEAL Initiative in April 2018 to speed scientific solutions to stem the national opioid public health crisis. It aims to prevent addiction through enhanced pain management and to improve treatment for opioid misuse disorder and addiction. This year, the HEAL Initiative has awarded $945 million to approximately 375 projects nationwide.
“It’s clear that a multi-pronged scientific approach is needed to reduce the risks of opioids, accelerate development of effective non-opioid therapies for pain and provide more flexible and effective options for treating addition to opioids,” NIH Director Francis S. Collins, MD, PhD, said in a press release about the awards. “This unprecedented investment in the NIH Heal Initiative demonstrates the commitment to reversing this devastating crisis.”